Geron | GERN - Ativos





Ativos Alterar Data
Amgen USD 95.64B 3.14B 2026-06
Bio Techne USD 2.55B 27.9M 2026-03
Cassava Sciences USD 108.37M 9.99M 2026-03
Cytokinetics USD 1.92B 651.07M 2026-06
Exelixis USD 2.59B 250.83M 2026-03
Genmab DKK 12.87B 5.85B 2025-12
Geron USD 519.01M 15.11M 2026-06
Gilead Sciences USD 49.36B 6.92B 2026-06
Incyte USD 7.87B 533.53M 2026-06
MacroGenics USD 217.87M 38.97M 2026-03
Novartis USD 122.03B 3.5B 2026-06
Novavax USD 955.58M 87.59M 2026-06